04/05/2026
Want to hear my conspiracy theory about Big Pharma and HRT?
Bear with me, because the numbers tell quite a story.
Body-identical HRT costs £19.80 a year on the NHS in England. Free in Scotland, Wales, and Northern Ireland. A medication that stabilises oestrogen, protects bone density, improves insulin sensitivity, supports cardiovascular health, and reduces all-cause mortality risk in midlife women.
For less than the price of a meal out.
Now consider the drugs that fill the gap when women are not offered HRT. Bisphosphonates for osteoporosis. Statins for cholesterol. Metformin and GLP-1 medications for insulin resistance and type 2 diabetes. Antidepressants prescribed to women in their 40s and 50s whose mood dysregulation is hormonal, not psychiatric. Antihypertensives for blood pressure that crept up after oestrogen withdrawal.
Each generates significant ongoing revenue. Each requires repeat prescriptions, monitoring appointments, and further medications to manage side effects.
HRT, by contrast, is cheap, effective, and preventive.
The wider economic picture rarely gets mentioned either. Menopause symptoms cost the UK economy billions annually through lost productivity, absenteeism, and women leaving the workforce at the peak of their careers. A woman cycling through GP appointments for brain fog, joint pain, and palpitations, each assessed in isolation, is an expensive patient. A woman on well-managed HRT, largely symptom-free, costs the system very little and contributes a great deal. The maths is not complicated. The will to act on it, apparently, is.
So why are we still treating the downstream consequences of oestrogen deficiency rather than addressing oestrogen deficiency itself?
The Women’s Health Initiative in 2002 caused HRT prescriptions to collapse overnight. The headlines screamed about breast cancer and heart attacks. What they did not say was that the trial used synthetic progestins in older women, years after menopause, with findings largely inapplicable to younger women using body-identical hormones at perimenopause. Two decades of under-prescribing followed. Women were handed antidepressants instead of oestrogen. Osteoporosis was managed rather than prevented.
The science has moved on. The prescribing largely has not.
So no, it is probably not a conspiracy.
But it is almost like they do not want us to be well.